Antithrombotics and Complications in Skin Grafts

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

172 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-01-31

Study Completion Date

2016-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Patients who were referred to cutaneous surgery and needed full thickness or split skin grafting and using antitrombotic or non-antitrombotic therapies were observed. Data on patient characteristics, diagnosis, location of surgery and surgery performed, antithrombotic medication and complications in skin grafts were collected. Skin grafts were traced on a transparent film and areas of unhealed skin graft were marked

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Platelet Reactivity in Patients on a Thienopyridine and Awaiting Coronary Artery Bypass Grafting

NCT01406483

Complication of Coronary Artery Bypass Graft Peri-operative Hemorrhage or Hematoma Post Operative Bleeding

COMPLETED NA

The Safety of Hand Surgery in the Anticoagulated Patient

NCT00954928

Hand Surgery

COMPLETED

Hip Fracture Surgery Timing and Blood Transfusion Risk in Patients on DOACs

NCT07309848

Blood Transfusion Hip Fracture Surgeries Geriatric +6 more

RECRUITING

The Effect of Topical Application of Tranexamic Acid in Total Hip Arthroplasty Through the Direct Anterior Approach

NCT01622946

Total Hip Arthroplasty Postoperative Blood Loss

COMPLETED PHASE4

Topical Tranexamic Acid and Acute Blood Loss in Total Hip Arthroplasty

NCT01683955

Acute Blood Loss Anemia Osteoarthritis, Hip

COMPLETED PHASE1

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Use of anticoagulants is common and practice regarding continuation or discontinuation of the medication peri-operatively for cutaneous surgery lacks evidence-based consensus. Therefore, patients who were referred to cutaneous surgery and needed full thickness or split skin grafting and using antitrombotic or non-antitrombotic therapies were observed. Data on patient characteristics, diagnosis, location of surgery and surgery performed, antithrombotic medication and complications in skin grafts were collected. Skin grafts were traced on a transparent film and areas of unhealed skin graft were marked

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Skin Graft Complications

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Patients referred to cutanous surgery with full thickness or split skin grafting. The excision should be performed on the levels of subcutis or perichondrium -